Skip to content
We've opened a community investment round!
Join Founders Fund, Lux Capital, and Innovation Endeavors as an investor.
Invest now
Home
Our Science
Therapeutic Areas
Team & Investors
Careers
News & Resources
Invest
News
& Resources
Featured Stories
Globe NewsWire
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Read More
Siren Biotechnology Opens Community Investment Round!
Read More
Press Release
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Read More
News
Patient Resources
Videos
All
Media Coverage
Press Releases
Press Releases
|
Posted on 5.12.25
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Read More
Media Coverage
|
Posted on 5.11.25
Siren, a gene therapy startup, tests unconventional alternative to venture funding
Read More
Media Coverage
|
Posted on 5.10.25
Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy
Read More
Media Coverage
|
Posted on 4.16.25
Siren community investment round featured in BiotechTV
Read More
Media Coverage
|
Posted on 4.16.25
Siren Biotechnology Opens Community Investment Round!
Read More
Media Coverage
|
Posted on 4.3.25
Siren CEO and Founder Dr. Nicole Paulk named in SFBT Women to Watch
Read More
Media Coverage
|
Posted on 4.3.25
Siren Biotechnology Presents at SXSW 2025
Read More
Press Releases
|
Posted on 3.4.25
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Read More
Media Coverage
|
Posted on 1.9.25
Siren Biotechnology named 2025 Company to Watch by Slice of Healthcare
Read More
Media Coverage
|
Posted on 12.13.24
Siren CEO and Founder Dr. Nicole Paulk honored in Slice of Healthcare’s 50 Under 50 list
Read More
1
2
3
…
5
